Activation_NN
and_CC
expression_NN
of_IN
the_DT
nuclear_JJ
factors_NNS
of_IN
activated_VBN
T_NN
cells_NNS
,_,
NFATp_NN
and_CC
NFATc_NN
,_,
in_IN
human_JJ
natural_JJ
killer_NN
cells_NNS
:_:
regulation_NN
upon_IN
CD16_NN
ligand_NN
binding_NN
._.

The_DT
putative_JJ
factors_NNS
that_WDT
couple_VBP
the_DT
signal_NN
transduction_NN
from_IN
surface_NN
receptors_NNS
to_TO
the_DT
activation_NN
of_IN
cytokine_NN
synthesis_NN
in_IN
natural_JJ
killer_NN
-LRB-_-LRB-
NK_NN
-RRB-_-RRB-
cells_NNS
have_VBP
not_RB
been_VBN
elucidated_VBN
._.

We_PRP
report_VBP
here_RB
that_IN
the_DT
nuclear_JJ
factor_NN
of_IN
activated_VBN
T_NN
cells_NNS
-LRB-_-LRB-
NFATp_NN
-RRB-_-RRB-
,_,
a_DT
cyclosporin_NN
A_NN
-LRB-_-LRB-
CsA_NN
-RRB-_-RRB-
-_:
sensitive_JJ
factor_NN
that_WDT
regulates_VBZ
the_DT
transcription_NN
of_IN
several_JJ
cytokines_NNS
,_,
mediates_VBZ
CD16-induced_JJ
activation_NN
of_IN
cytokine_NN
genes_NNS
in_IN
human_JJ
NK_NN
cells_NNS
._.

CD16_NN
-LRB-_-LRB-
Fc_NN
gamma_NN
RIIIA_NN
-RRB-_-RRB-
-_:
induced_JJ
expression_NN
of_IN
cytokine_NN
mRNA_NN
in_IN
NK_NN
cells_NNS
occurs_VBZ
via_IN
a_DT
CsA-sensitive_JJ
and_CC
Ca_NN
-LRB-_-LRB-
2_CD
+_NN
-RRB-_-RRB-
-_:
dependent_JJ
mechanism_NN
._.

Stimulation_NN
of_IN
NK_NN
cells_NNS
with_IN
CD16_NN
ligands_NNS
induces_VBZ
NFAT-like_JJ
DNA_NN
binding_NN
activity_NN
in_IN
the_DT
nuclear_JJ
extracts_NNS
from_IN
these_DT
cells_NNS
,_,
as_IN
detected_VBN
in_IN
electrophoretic_JJ
mobility_NN
shift_NN
assays_NNS
._.

This_DT
occurs_VBZ
with_IN
fast_JJ
kinetics_NNS
after_IN
stimulation_NN
,_,
via_IN
a_DT
CsA-sensitive_JJ
and_CC
Ca_NN
-LRB-_-LRB-
2_CD
+_NN
-RRB-_-RRB-
-_:
dependent_JJ
mechanism_NN
that_WDT
does_VBZ
not_RB
require_VB
de_FW
novo_FW
protein_NN
synthesis_NN
._.

NK_NN
cell_NN
NFAT_NN
is_VBZ
present_JJ
in_IN
the_DT
cytosol_NN
of_IN
nonstimulated_JJ
cells_NNS
,_,
migrates_VBZ
to_TO
the_DT
nucleus_NN
upon_IN
stimulation_NN
,_,
and_CC
can_MD
associate_VB
with_IN
AP-1_NN
._.

Two_CD
distinct_JJ
molecules_NNS
,_,
NFATp_NN
and_CC
NFATc_NN
,_,
have_VBP
been_VBN
reported_VBN
to_TO
mediate_VB
NFAT_NN
activity_NN
._.

The_DT
results_NNS
of_IN
supershift_NN
assays_NNS
using_VBG
NFATp_NN
-_:
and_CC
NFATc-specific_JJ
antibodies_NNS
indicate_VBP
that_IN
NK_NN
cell_NN
activation_NN
early_JJ
after_IN
CD16_NN
ligand_NN
binding_NN
involves_VBZ
primarily_RB
,_,
if_IN
not_RB
exclusively_RB
,_,
NFATp_NN
,_,
and_CC
Western_NN
blot_NN
analysis_NN
shows_VBZ
that_IN
this_DT
has_VBZ
the_DT
same_JJ
electrophoretic_JJ
mobility_NN
-LRB-_-LRB-
approximately_RB
120_CD
kD_NN
-RRB-_-RRB-
as_IN
that_DT
of_IN
T_NN
lymphocytes_NNS
._.

NK_NN
cells_NNS
do_VBP
not_RB
express_VB
NFATc_NN
constitutively_RB
,_,
but_CC
NFATc_NN
mRNA_NN
accumulation_NN
is_VBZ
induced_VBN
in_IN
these_DT
cells_NNS
within_IN
2_CD
h_NN
of_IN
stimulation_NN
with_IN
CD16_NN
ligands_NNS
._.

However_RB
,_,
supershift_NN
assays_NNS
using_VBG
the_DT
available_JJ
mAb_NN
recognizing_VBG
the_DT
T_NN
cell_NN
NFATc_NN
revealed_VBD
no_DT
detectable_JJ
NFATc_NN
protein_NN
in_IN
nuclear_JJ
and_CC
cytoplasmic_JJ
extracts_NNS
from_IN
CD16_NN
-_:
or_CC
phorbol_NN
ester-stimulated_JJ
cells_NNS
at_IN
any_DT
time_NN
tested_VBN
,_,
up_RB
to_TO
4_CD
h_NN
._.

These_DT
results_NNS
provide_VBP
the_DT
first_JJ
direct_JJ
evidence_NN
that_IN
both_DT
CsA-sensitive_JJ
transcription_NN
factors_NNS
,_,
NFATp_NN
and_CC
NFATc_NN
,_,
are_VBP
expressed_VBN
in_IN
human_JJ
NK_NN
cells_NNS
,_,
and_CC
that_IN
their_PRP$
activation_NN
and\/or_CC
expression_NN
can_MD
be_VB
regulated_VBN
in_IN
primary_JJ
cells_NNS
by_IN
a_DT
single_JJ
stimulus_NN
,_,
that_WDT
,_,
in_IN
the_DT
case_NN
of_IN
CD16_NN
in_IN
NK_NN
cells_NNS
,_,
results_VBZ
in_IN
early_JJ
activation_NN
of_IN
NFATp_NN
and_CC
subsequently_RB
induced_VBD
expression_NN
of_IN
NFATc_NN
mRNA_NN
._.

